Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
1176
Happen Inc
HAPN
$2.11B
| $6.59M | 0.01% |
+119,235
| New | +$7.91M |
|
|
CADE
1177
DELISTED
Cadence Bank
CADE
| $6.59M | 0.01% |
+274,589
| New | +$6.88M |
|
|
MDR
1178
DELISTED
McDermott International
MDR
| $6.58M | 0.01% |
654,392
-288,151
| -31% | -$3.95M |
|
|
ORBK
1179
DELISTED
Orbotech Ltd
ORBK
| $6.57M | 0.01% |
296,726
+232,367
| +361% | +$4.35M |
|
1180
CALL
Teva Pharmaceuticals
TEVA
$43B
| $6.56M | 0.01% |
+100,000
| New | +$6.18M |
|
1181
Cardinal Health
CAH
$54B
| $6.56M | 0.01% |
73,457
-476,238
| -87% | -$40.4M |
|
|
ABMD
1182
DELISTED
Abiomed Inc
ABMD
| $6.54M | 0.01% |
72,489
-8,778
| -11% | -$745K |
|
|
TYPE
1183
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $6.54M | 0.01% |
276,727
+117,329
| +74% | +$2.88M |
|
|
CSGS
1184
DELISTED
CSG Systems International
CSGS
| $6.53M | 0.01% |
181,384
-107,063
| -37% | -$3.68M |
|
|
PCH
1185
DELISTED
PotlatchDeltic
PCH
| $6.51M | 0.01% |
215,203
-262,786
| -55% | -$8.22M |
|
1186
Pegasystems
PEGA
$5.64B
| $6.51M | 0.01% |
473,186
-124,388
| -21% | -$1.72M |
|
1187
RingCentral
RNG
$5.6B
| $6.51M | 0.01% |
275,908
-190,744
| -41% | -$4.11M |
|
1188
PUT
Alibaba
BABA
$284B
| $6.5M | 0.01% |
80,000
+30,000
| +60% | +$2.35M |
|
1189
Brown & Brown
BRO
$25B
| $6.46M | 0.01% |
+402,416
| New | +$6.44M |
|
|
TAST
1190
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $6.46M | 0.01% |
550,210
+142,532
| +35% | +$1.7M |
|
1191
Genpact
G
$6.32B
| $6.45M | 0.01% |
258,270
+119,339
| +86% | +$2.95M |
|
1192
TransDigm Group
TDG
$66.3B
| $6.45M | 0.01% |
28,243
+6,027
| +27% | +$1.36M |
|
1193
ScottsMiracle-Gro
SMG
$3.53B
| $6.44M | 0.01% |
99,776
-291,724
| -75% | -$19.3M |
|
|
DNR
1194
DELISTED
Denbury Resources, Inc.
DNR
| $6.43M | 0.01% |
3,185,362
+1,083,022
| +52% | +$3.49M |
|
|
COHR
1195
DELISTED
Coherent Inc
COHR
| $6.43M | 0.01% |
98,764
+72,694
| +279% | +$4.48M |
|
|
ACOR
1196
CALL
DELISTED
Acorda Therapeutics
ACOR
| $6.42M | 0.01% |
+1,250
| New | +$5.46M |
|
1197
First Industrial Realty Trust
FR
$8.41B
| $6.42M | 0.01% |
289,889
-735,722
| -72% | -$16.2M |
|
1198
Prologis
PLD
$136B
| $6.41M | 0.01% |
+149,432
| New | +$6.3M |
|
|
RP
1199
DELISTED
RealPage, Inc.
RP
| $6.41M | 0.01% |
285,680
+126,066
| +79% | +$2.56M |
|
|
MRC
1200
DELISTED
MRC Global
MRC
| $6.41M | 0.01% |
496,933
+277,405
| +126% | +$3.65M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.